Immunoprecise Antibodies Ltd (IPA) — Tangible Net Worth Ratio
Immunoprecise Antibodies Ltd (IPA) has a Tangible Net Worth Ratio of 95.5% as of April 2025. This metric is calculated by deducting intangible assets ($1.07 Million) from net assets ($23.63 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Immunoprecise Antibodies Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Immunoprecise Antibodies Ltd Tangible Net Worth Ratio (1997–2025)
This chart shows how Immunoprecise Antibodies Ltd's Tangible Net Worth Ratio has changed across 25 annual periods from 1997 to 2025. As of April 2025, the ratio stands at 95.5%, reflecting net assets of $23.63 Million with intangible assets of $1.07 Million USD. See IPA days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Immunoprecise Antibodies Ltd (1997–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Immunoprecise Antibodies Ltd from 1997 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see IPA stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.5% | $23.63 Million | $1.07 Million | $44.44 Million | ▲ +64.9 pp |
| 2024 | 30.6% | $33.92 Million | $23.56 Million | $59.99 Million | ▼ -15.9 pp |
| 2023 | 46.5% | $57.80 Million | $30.93 Million | $77.81 Million | ▼ -10.5 pp |
| 2022 | 57.0% | $75.28 Million | $32.39 Million | $93.49 Million | ▼ -32.4 pp |
| 2021 | 89.4% | $56.92 Million | $6.06 Million | $66.96 Million | ▲ +44.3 pp |
| 2020 | 45.1% | $15.09 Million | $8.29 Million | $27.26 Million | ▼ -8.3 pp |
| 2019 | 53.4% | $18.07 Million | $8.42 Million | $28.35 Million | ▼ -14.8 pp |
| 2018 | 68.2% | $12.70 Million | $4.04 Million | $24.58 Million | ▼ -31.8 pp |
| 2017 | 100.0% | $3.09 Million | $0.00 | $3.93 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $908.26K | $0.00 | $1.38 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $158.40K | $0.00 | $268.61K | ▲ +0.0 pp |
| 2010 | 100.0% | $5.43 Million | $0.00 | $5.53 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $6.78 Million | $0.00 | $6.93 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $5.12 Million | $0.00 | $5.16 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $5.43 Million | $0.00 | $5.84 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $3.91 Million | $0.00 | $4.05 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $4.23 Million | $0.00 | $4.28 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $1.39 Million | $0.00 | $1.44 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $867.54K | $0.00 | $897.07K | ▲ +0.0 pp |
| 2002 | 100.0% | $691.56K | $0.00 | $879.28K | ▲ +0.0 pp |
| 2001 | 100.0% | $262.24K | $0.00 | $1.16 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $396.53K | $0.00 | $406.64K | ▲ +0.0 pp |
| 1999 | 100.0% | $1.62 Million | $0.00 | $1.66 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $2.86 Million | $0.00 | $2.93 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $3.63 Million | $0.00 | $3.88 Million | — |